This site is for US healthcare professionals only
Skip to content
Corcept Therapeutics
  • Home
    • Endocrinology Home
    • Oncology Home
  • Medical Information
    • Find My MSL
    • Connect With the Corcept Medical Information Contact Center
    • Submit a Medical Inquiry
  • Congress Materials
    • Endocrinology Congress Materials
    • Oncology Congress Materials
  • Publications
    • Endocrinology Publications
    • Oncology Publications
  • Resources
    • Endocrinology Resources
    • Oncology Resources

Search

Adverse Event Reporting Information

Submit a Medical Inquiry

To report a medical adverse event, side effect, or product complaint, please call 1-855-844-3270.
Mon-Fri 8am – 8pm ET

You may also contact the U.S. Food and Drug Administration
MedWatch Adverse Event Reporting program:
Online: www.fda.gov/medwatch
Telephone: 1-800-FDA-1088

home / oncology / 2023

Therapeutic Area

2023

Find My MSL

Submit a Medical Inquiry

Adverse Event Reporting Information

2023

Poster

ROSELLA (GOG-3073, ENGOT-OV72/MITO): A Phase 3 Study of Relacorilant + Nab-paclitaxel vs. Nab-paclitaxel in Platinum-Resistant Ovarian Cancer

International Gynecologic Cancer Society (IGCS) Annual Global Meeting

2023

Poster

ROSELLA, GOG‑3073, ENGOT‑OV72/MITO: A Phase 3 Study of Relacorilant + Nab‑paclitaxel vs. Nab‑paclitaxel in Advanced, Platinum-resistant Ovarian Cancer

European Society of Gynaecological Oncology (ESGO) Congress

2023

Presentation

Selective Glucocorticoid Receptor Modulation Reveals a New Role for CLEC10A in Patients With Solid Tumors

American Association for Cancer Research (AACR) Annual Meeting

2023

Poster

ROSELLA, GOG‑3073, ENGOT‑OV72/MITO: A Phase 3 Study of Relacorilant + Nab‑paclitaxel vs. Nab‑paclitaxel in Advanced, Platinum-resistant Ovarian Cancer

Society of Gynecologic Oncology (SGO) Annual Meeting

2023

Poster

Phase 1 Efficacy and Pharmacodynamic Results of Exicorilant + Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium

2023

About Corcept Contact Us Privacy Policy Terms of Use Hypercortisolism Portal Login

©2026 Corcept Therapeutics Incorporated. All rights reserved.

MA-FLD-00432

You are leaving Corcept Medical

Click continue to proceed to the external link.

Continue

To report a medical adverse event, side effect, or product complaint, please call 1-855-844-3270.
Mon-Fri 8am – 8pm ET

You may also contact the U.S. Food and Drug Administration MedWatch Adverse Event Reporting program:
Online: www.fda.gov/medwatch
Telephone: 1-800-FDA-1088

Search